{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:22:20Z","timestamp":1789042940508,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jaut.2026.103559","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T20:26:03Z","timestamp":1777321563000},"page":"103559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["HCV-related cryoglobulinemic vasculitis (mixed cryoglobulinemia syndrome) in the era of direct-acting antivirals: A 10-year experience from Italian tertiary referral centers"],"prefix":"10.1016","volume":"161","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0840-5817","authenticated-orcid":false,"given":"Clodoveo","family":"Ferri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Visentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Vacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Lauletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Naclerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"De Giorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresita","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"D'Ambrosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"D'Arcangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Marri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poupak","family":"Fallhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Linda","family":"Zignego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilia","family":"Giuggioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6800-9149","authenticated-orcid":false,"given":"Laura","family":"Gragnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milvia","family":"Casato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jaut.2026.103559_bib1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0002-9343(66)90200-2","article-title":"Cryoglobulinemia--a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity","volume":"40","author":"Meltzer","year":"1966","journal-title":"Am. J. Med."},{"issue":"5","key":"10.1016\/j.jaut.2026.103559_bib2","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","article-title":"Biologic and clinical significance of cryoglobulins. A report of 86 cases","volume":"57","author":"Brouet","year":"1974","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.jaut.2026.103559_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jcp.55.1.4","article-title":"Cryoglobulins","volume":"55","author":"Ferri","year":"2002","journal-title":"J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.jaut.2026.103559_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-018-0009-4","article-title":"Cryoglobulinaemia","volume":"4","author":"Roccatello","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"12","key":"10.1016\/j.jaut.2026.103559_bib5","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.autrev.2016.09.006","article-title":"International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement","volume":"15","author":"Ferri","year":"2016","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.jaut.2026.103559_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/bjh.19112","article-title":"Clinical and clonal characteristics of monoclonal immunoglobulin M-associated type I cryoglobulinaemia","volume":"204","author":"Khwaja","year":"2024","journal-title":"Br. J. Haematol."},{"issue":"15","key":"10.1016\/j.jaut.2026.103559_bib7","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1056\/NEJMra2400092","article-title":"Cryoglobulinemia - one name for two diseases","volume":"391","author":"Cacoub","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.jaut.2026.103559_bib8","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/art.1780341221","article-title":"Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia","volume":"34","author":"Ferri","year":"1991","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.jaut.2026.103559_bib9","first-page":"621","article-title":"Association between hepatitis C virus and mixed cryoglobulinemia","volume":"9","author":"Ferri","year":"1991","journal-title":"Clin. Exp. Rheumatol."},{"issue":"21","key":"10.1016\/j.jaut.2026.103559_bib10","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1056\/NEJM199211193272104","article-title":"A role for hepatitis C virus infection in type II cryoglobulinemia","volume":"327","author":"Agnello","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2026.103559_bib11","series-title":"EULAR Compendium on Rheumatic Diseases","first-page":"1042","article-title":"EULAR compendium on rheumatic diseases","author":"Ferri","year":"2012"},{"issue":"6","key":"10.1016\/j.jaut.2026.103559_bib12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.autrev.2013.11.005","article-title":"Prevalence of mixed cryoglobulinaemia syndrome and circulating cryoglobulins in a population-based survey: the Origgio study","volume":"13","author":"Monti","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.jaut.2026.103559_bib13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10238-022-00808-1","article-title":"The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements","volume":"23","author":"Dammacco","year":"2023","journal-title":"Clin. Exp. Med."},{"issue":"10","key":"10.1016\/j.jaut.2026.103559_bib14","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-2893.2007.00866.x","article-title":"Cryoglobulinaemia associated with hepatitis C virus: influence of HCV genotypes, HCV-RNA viraemia and HIV coinfection","volume":"14","author":"Ramos-Casals","year":"2007","journal-title":"J. Viral Hepat."},{"issue":"11","key":"10.1016\/j.jaut.2026.103559_bib15","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/rheumatology\/kem209","article-title":"Bone marrow B-cell clonal expansion in type II mixed cryoglobulinaemia: association with nephritis","volume":"46","author":"Quartuccio","year":"2007","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.jaut.2026.103559_bib16","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.autrev.2011.01.008","article-title":"Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients","volume":"10","author":"Pietrogrande","year":"2011","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.jaut.2026.103559_bib17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.autrev.2017.03.004","article-title":"International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement","volume":"16","author":"Zignego","year":"2017","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.jaut.2026.103559_bib18","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jhep.2024.04.007","article-title":"EASL position paper on clinical follow-up after HCV cure","volume":"81","author":"Reiberger","year":"2024","journal-title":"J. Hepatol."},{"issue":"1 Suppl","key":"10.1016\/j.jaut.2026.103559_bib19","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/j.jhep.2015.02.006","article-title":"From non-A, non-B hepatitis to hepatitis C virus cure","volume":"62","author":"Pawlotsky","year":"2015","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.jaut.2026.103559_bib20","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/hep.27623","article-title":"Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label, cohort study","volume":"61","author":"Gragnani","year":"2015","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.jaut.2026.103559_bib21","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.dld.2014.05.017","article-title":"Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: a prospective, controlled pilot study","volume":"46","author":"Gragnani","year":"2014","journal-title":"Dig. Liver Dis."},{"issue":"1","key":"10.1016\/j.jaut.2026.103559_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jhep.2014.08.015","article-title":"PegIFN\u03b1\/ribavirin\/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis","volume":"62","author":"Saadoun","year":"2015","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.jaut.2026.103559_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2014-206180","article-title":"Treatment of chronic hepatitis C complicated by mixed cryoglobulinemia with new protease inhibitor, sofosbuvir","volume":"73","author":"Stine","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.jaut.2026.103559_bib24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/00325481.2015.1021660","article-title":"Persistence of mixed cryoglobulinemia despite cure of hepatitis C with new oral antiviral therapy including direct-acting antiviral sofosbuvir: a case series","volume":"127","author":"Cornella","year":"2015","journal-title":"Postgrad. Med. J."},{"issue":"11","key":"10.1016\/j.jaut.2026.103559_bib25","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1136\/gutjnl-2015-310421","article-title":"Hepatitis C virus treatment in the real world: optimising treatment and access to therapies","volume":"64","author":"Zoulim","year":"2015","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.jaut.2026.103559_bib26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1053\/j.gastro.2018.04.024","article-title":"Long-Term outcomes of patients with HCV-associated cryoglobulinemic vasculitis after virologic cure","volume":"155","author":"Bonacci","year":"2018","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jaut.2026.103559_bib27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/hep.32281","article-title":"A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort","volume":"76","author":"Kondili","year":"2022","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jaut.2026.103559_bib28","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/hep.28753","article-title":"Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia","volume":"64","author":"Gragnani","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jaut.2026.103559_bib29","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/hep.28297","article-title":"Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents","volume":"63","author":"Sise","year":"2016","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.jaut.2026.103559_bib30","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/MEG.0000000000001239","article-title":"Are direct-acting antivirals safe and effective in hepatitis C virus-cryoglobulinemia? Virological, immunological, and clinical data from a real-life experience","volume":"30","author":"Passerini","year":"2018","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2026.103559_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31804","article-title":"Hematological and genetic markers in the rational approach to patients with HCV sustained virological response with or without persisting cryoglobulinemic vasculitis","author":"Gragnani","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jaut.2026.103559_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102923","article-title":"Predictors of long-term cryoglobulinemic vasculitis outcomes after HCV eradication with direct-acting antivirals in the real-life","volume":"21","author":"Gragnani","year":"2022","journal-title":"Autoimmun. Rev."},{"issue":"8","key":"10.1016\/j.jaut.2026.103559_bib33","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/ajg.2017.49","article-title":"Efficacy and safety of direct acting antivirals for the treatment of mixed cryoglobulinemia","volume":"112","author":"Emery","year":"2017","journal-title":"Am. J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.jaut.2026.103559_bib34","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1136\/annrheumdis-2015-208339","article-title":"Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study","volume":"75","author":"Saadoun","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.jaut.2026.103559_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/j.gastro.2017.03.006","article-title":"Efficacy and safety of Sofosbuvir plus Daclatasvir for treatment of HCV-associated cryoglobulinemia vasculitis","volume":"153","author":"Saadoun","year":"2017","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jaut.2026.103559_bib36","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.cgh.2018.05.021","article-title":"Long-term efficacy of Interferon-free antiviral treatment regimens in patients with hepatitis C virus-associated Cryoglobulinemia vasculitis","volume":"17","author":"Cacoub","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.jaut.2026.103559_bib37","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/apt.14845","article-title":"Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis","volume":"48","author":"Gragnani","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.jaut.2026.103559_bib38","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1093\/rheumatology\/kew268","article-title":"Persistent mixed cryoglobulinaemia vasculitis despite hepatitis C virus eradication after interferon-free antiviral therapy","volume":"55","author":"Sollima","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.jaut.2026.103559_bib39","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/rheumatology\/key157","article-title":"Late relapses of hepatitis C virus-cured mixed cryoglobulinaemia associated with infection or cancer","volume":"57","author":"Visentini","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.jaut.2026.103559_bib40","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13075-017-1280-6","article-title":"Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience","volume":"19","author":"Lauletta","year":"2017","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.jaut.2026.103559_bib41","first-page":"107","article-title":"Long-term effects of the new direct antiviral agents (DAAs) therapy for HCV-related mixed cryoglobulinaemia without renal involvement: a multicentre open-label study","volume":"36","author":"Mazzaro","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2","key":"10.1016\/j.jaut.2026.103559_bib42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/sdi.12758","article-title":"Considering hepatitis C virus infection as a systemic disease","volume":"32","author":"Cacoub","year":"2019","journal-title":"Semin. Dial."},{"key":"10.1016\/j.jaut.2026.103559_bib43","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.17036","article-title":"Direct-acting antiviral agents for hepatitis C virus-mixed cryoglobulinaemia: dissociated virological and haematological responses","author":"Pozzato","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"12","key":"10.1016\/j.jaut.2026.103559_bib44","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1093\/rheumatology\/keu271","article-title":"Validation of the classification criteria for cryoglobulinaemic vasculitis","volume":"53","author":"Quartuccio","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.jaut.2026.103559_bib45","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jhep.2015.03.025","article-title":"EASL recommendations on treatment of hepatitis C 2015","volume":"63","year":"2015","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.jaut.2026.103559_bib46","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: final update of the series","volume":"73","year":"2020","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.jaut.2026.103559_bib47","first-page":"889","article-title":"Peripheral neuropathy in mixed cryoglobulinemia: clinical and electrophysiologic investigations","volume":"19","author":"Ferri","year":"1992","journal-title":"J. Rheumatol."},{"issue":"10","key":"10.1016\/j.jaut.2026.103559_bib48","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/rheumatology\/35.10.978","article-title":"Bronchoalveolar lavage in mixed cryoglobulinaemia associated with hepatitis C virus","volume":"35","author":"Manganelli","year":"1996","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.jaut.2026.103559_bib49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1750-1172-3-25","article-title":"Mixed cryoglobulinemia","volume":"3","author":"Ferri","year":"2008","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.jaut.2026.103559_bib50","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13023-024-03159-0","article-title":"Clinical characteristics, radiological features and outcomes in pulmonary involvement of cryoglobulinemia","volume":"19","author":"Han","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.jaut.2026.103559_bib51","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/rheumatology\/36.3.360","article-title":"Interstitial lung fibrosis and rheumatic disorders in patients with hepatitis C virus infection","volume":"36","author":"Ferri","year":"1997","journal-title":"Br. J. Rheumatol."},{"issue":"3","key":"10.1016\/j.jaut.2026.103559_bib52","first-page":"149","article-title":"Central nervous system involvement in HCV-related mixed cryoglobulinemia","volume":"46","author":"Cappellari","year":"2006","journal-title":"Electromyogr. Clin. Neurophysiol."},{"issue":"3","key":"10.1016\/j.jaut.2026.103559_bib53","first-page":"484","article-title":"Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: a multicenter case-control study using magnetic resonance imaging and neuropsychological tests","volume":"32","author":"Casato","year":"2005","journal-title":"J. Rheumatol."},{"issue":"7","key":"10.1016\/j.jaut.2026.103559_bib54","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.jaut.2026.103559_bib55","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.semarthrit.2003.10.001","article-title":"Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients","volume":"33","author":"Ferri","year":"2004","journal-title":"Semin. Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.jaut.2026.103559_bib56","doi-asserted-by":"crossref","first-page":"627","DOI":"10.14309\/ajg.0000000000001667","article-title":"Relapse of Hepatitis C virus cryoglobulinemic vasculitis after sustained viral response after interferon-free direct-acting antivirals","volume":"117","author":"Fayed","year":"2022","journal-title":"Am. J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.jaut.2026.103559_bib57","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1007\/s10620-025-09033-8","article-title":"Long term Follow-Up of patients with cryoglobulinemia after successful treatment of chronic C virus hepatitis","volume":"70","author":"Elthes","year":"2025","journal-title":"Dig. Dis. Sci."},{"issue":"3","key":"10.1016\/j.jaut.2026.103559_bib58","doi-asserted-by":"crossref","first-page":"284","DOI":"10.23736\/S0026-4806.24.09170-5","article-title":"Hepatitis C virus-related autoimmunity before and after viral clearance: a single center, prospective, observational study","volume":"115","author":"Lauletta","year":"2024","journal-title":"Minerva Med."},{"issue":"2","key":"10.1016\/j.jaut.2026.103559_bib59","first-page":"161","article-title":"Recurrence of mixed cryoglobulinaemia vasculitis following influenza vaccination despite clearance of hepatitis C virus infection","volume":"36","author":"Sollima","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.jaut.2026.103559_bib60","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jhep.2021.09.023","article-title":"HCV-related lymphoproliferative disorders in the direct-acting antiviral era: from mixed cryoglobulinaemia to B-cell lymphoma","volume":"76","author":"Cacoub","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2026.103559_bib61","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejim.2019.05.016","article-title":"CD5\/CD20 expression on circulating B cells in HCV-related chronic hepatitis and mixed cryoglobulinemia","volume":"66","author":"Russi","year":"2019","journal-title":"Eur. J. Intern. Med."},{"issue":"2","key":"10.1016\/j.jaut.2026.103559_bib62","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.immuni.2024.12.011","article-title":"A triad of somatic mutagenesis converges in self-reactive B cells to cause a virus-induced autoimmune disease","volume":"58","author":"Young","year":"2025","journal-title":"Immunity"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841126000375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841126000375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:58:12Z","timestamp":1781135892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841126000375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":62,"alternative-id":["S0896841126000375"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2026.103559","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HCV-related cryoglobulinemic vasculitis (mixed cryoglobulinemia syndrome) in the era of direct-acting antivirals: A 10-year experience from Italian tertiary referral centers","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2026.103559","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103559"}}